首页> 美国卫生研究院文献>other >Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results
【2h】

Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results

机译:脑源性神经营养因子基因Val66Met多态性与氯氮平诱导的代谢综合征的关联研究:初步结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prevalence of the metabolic syndrome (MetS) is higher among patients receiving atypical antipsychotics (AAPs) treatment, and even among AAPs, treatment with clozapine has been shown to be associated with a higher long-term incidence rate of MetS. Likewise, brain-derived neurotrophic factor (BDNF) deficiency has been reported to result in metabolic traits, such as increased food intake, hyperphagia and obesity, etc. In this study, we hypothesized that a functional polymorphism (Val66Met) in the BDNF gene may confer susceptibility to clozapine-induced MetS, potentially in a sex-specific manner, since an interaction between Val66Met polymorphism and sex was observed in our previous studies. A total of 199 schizophrenia patients being treated with clozapine were divided into two groups, MetS and non-MetS, based on the diagnostic criteria of the National Cholesterol Education Program's Adult Treatment Panel III. We genotyped the Val66Met polymorphism, and measured the serum levels of fasting glucose (GLU), triglyceride (TG) and high density lipoprotein cholesterol (HDL). There was a trend indicating a significant association between the homozygous Met/Met genotype and MetS in male patients (OR = 2.39; 95% CI: 1.05–5.41; p = 0.039; corrected p = 0.078). Among the six risk factors listed in the ATPIII criteria, we found a significant association between fasting GLU levels and Val66Met polymorphism in males (p = 0.005; corrected p = 0.03), but not in females (p = 0.65). Post-hoc analysis in males revealed that the Met/Met carriers had significant higher levels of fasting GLU than those with Val/Val or Val/Met genotypes (p = 0.007; corrected p = 0.042 and p = 0.002; corrected p = 0.012, respectively). In conclusion, we observed a weak association between the Val66Met polymorphism and clozapine-induced MetS in a sex-specific manner. While preliminary, such findings prompt further, large-scale longitudinal studies to replicate these findings.
机译:在接受非典型抗精神病药(AAP)治疗的患者中,代谢综合征(MetS)的患病率更高,甚至在AAP中,氯氮平治疗也被证明与MetS的长期发生率较高相关。同样,据报道脑源性神经营养因子(BDNF)缺乏会导致代谢特征,例如食物摄入增加,食欲亢进和肥胖等。在这项研究中,我们假设BDNF基因中的功能多态性(Val66Met)可能由于我们以前的研究中观察到Val66Met多态性与性别之间的相互作用,因此可能以性别特异性的方式赋予氯氮平诱导的MetS敏感性。根据美国国家胆固醇教育计划成人治疗小组III的诊断标准,总共199名接受氯氮平治疗的精神分裂症患者分为MetS和非Mets两组。我们对Val66Met多态性进行了基因分型,并测量了空腹血糖(GLU),甘油三酸酯(TG)和高密度脂蛋白胆固醇(HDL)的血清水平。有趋势表明男性患者的纯合的Met / Met基因型与MetS之间存在显着相关性(OR = 2.39; 95%CI:1.05-5.41; p = 0.039;校正后的p = 0.078)。在ATPIII标准中列出的六个危险因素中,我们发现男性的空腹GLU水平与Val66Met多态性之间存在显着相关性(p = 0.005;校正后的p = 0.03),而女性没有(p = 0.65)。男性事后分析显示,Met / Met携带者的空腹GLU水平明显高于Val / Val或Val / Met基因型的空腹GLU(p = 0.007;校正后的p = 0.042和p = 0.002;校正的p =,0.012,分别)。总之,我们观察到Val66Met多态性与氯氮平诱导的MetS之间存在性别相关的弱关联。虽然是初步的,但这些发现促使人们进行进一步的大规模纵向研究来复制这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号